SCHEMBL3762847

SCHEMBL3762847

Cc1ccsc1C(=O)N1CCN(CC(=O)N2CCN(C3CCC3)CC2)CC1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.45
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
CA7 P43166 1/20 0.45
CA9 Q16790 1/20 0.45
ALDH1A1 P00352 5/20 0.45
HPGD P15428 1/20 0.45
SIGLEC9 Q9Y336 1/20 0.44
KDM4E B2RXH2 2/20 0.43
LMNA P02545 1/20 0.42
PARP1 P09874 1/20 0.42
HRH3 Q9Y5N1 2/20 0.42
TSHR P16473 1/20 0.41
KMT2A Q03164 1/20 0.41
HTT P42858 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
CHRM2 P08172 1/20 0.41
L3MBTL3 Q96JM7 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3774846 0.87 CA12 (0.46) CA12CA1CA2CA7CA9
SCHEMBL3767697 0.87 ALDH1A1 (0.47) ALDH1A1HPGDKDM4EPARP1HRH3
SCHEMBL3769128 0.84 KMT2A (0.44) ALDH1A1HPGDKDM4ELMNAPARP1
SCHEMBL3763003 0.81 CCR5 (0.58) ALDH1A1HPGDKDM4EPARP1HRH3
SCHEMBL3767212 0.80 HTT (0.56) ALDH1A1KDM4EPARP1HTTNPSR1
SCHEMBL3762910 0.80 ALDH1A1 (0.54) ALDH1A1HPGDHRH3TSHRKMT2A
SCHEMBL3773975 0.80 ALDH1A1 (0.58) ALDH1A1KDM4ELMNATSHRKMT2A
SCHEMBL3766156 0.79 USP2 (0.62) ALDH1A1KDM4EHRH3L3MBTL3L3MBTL1
SCHEMBL3771922 0.79 ALDH1A1 (0.74) ALDH1A1HPGDKDM4EPARP1HRH3
SCHEMBL3765908 0.78 CCR5 (0.45) ALDH1A1HPGDKDM4EPARP1HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7851474-B2 Dipiperazinyl ketones and related analogues NEUROGEN CORPORATION (US) 2010-12-14 US disclosed
US-7851474-B2 Dipiperazinyl ketones and related analogues NEUROGEN CORPORATION (US) 2010-12-14 US disclosed
US-7851474-B2 Dipiperazinyl ketones and related analogues NEUROGEN CORPORATION (US) 2010-12-14 US disclosed
US-20070049571-A1 Dipiperazinyl ketones and related analogues NEUROGEN CORPORATION 2007-03-01 US disclosed
US-20070049571-A1 Dipiperazinyl ketones and related analogues NEUROGEN CORPORATION 2007-03-01 US disclosed
US-20070049571-A1 Dipiperazinyl ketones and related analogues NEUROGEN CORPORATION 2007-03-01 US disclosed
WO-2007016496-A2 DIPIPERAZINYL KETONES AND RELATED ANALOGUES NEUROGEN CORPORATION (US) 2007-02-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070049571-A1 Dipiperazinyl ketones and related analogues HRH4, HRH3, HRH1 CA12 2029/4885CA1 1994/4885CA2 2484/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.